
Truist raises RXO price target to $28 after strong Q2 revenue and profit beat.
Truist Financial raised its price target for RXO to $28, signaling a 30% potential gain after the company reported strong Q2 results. RXO posted $1.77 billion in revenue, a 25% increase year-over-year, surpassing analyst estimates by nearly 15%. Earn...


